RESCAP in severe burn wound trial

Alloksys's RESCAP platform therapeutic compound will be applied in patients that suffer from severe burn trauma. RESCAP administration is expected to significantly attenuate the overall ischemic clinical condition of these…

Continue Reading

January 2020 APPIRED III

APPIRED III study is getting well on its way with 9 centres started with including patients. These centres are Singapore NUH, CZE Eindhoven, Jessa, Hasselt, UniMed Wien Vienna, Almazov Heart…

Continue Reading
  • 1
  • 2
Close Menu